000			02164 a2200505 4500
005			20250514020805.0
264		0	_c20020128
008			200201s 0 0 eng d
022			_a0893-133X
024	7		_a10.1016/S0893-133X(01)00346-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aKrupitsky, E M
245	0	0	_aAttenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists. _h[electronic resource]
260			_bNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _cDec 2001
300			_a936-47 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAffect _xdrug effects
650	0	4	_aAlcoholism _xmetabolism
650	0	4	_aAnxiety _xpsychology
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCalcium Channel Blockers _xpharmacology
650	0	4	_aCalcium Channels, L-Type _xdrug effects
650	0	4	_aDepressive Disorder _xpsychology
650	0	4	_aDouble-Blind Method
650	0	4	_aEuphoria _xdrug effects
650	0	4	_aExcitatory Amino Acid Antagonists _xpharmacology
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aHumans
650	0	4	_aKetamine _xantagonists & inhibitors
650	0	4	_aMale
650	0	4	_aNimodipine _xpharmacology
650	0	4	_aPsychiatric Status Rating Scales
650	0	4	_aReceptors, N-Methyl-D-Aspartate _xdrug effects
650	0	4	_aVerbal Behavior _xdrug effects
700	1		_aBurakov, A M
700	1		_aRomanova, T N
700	1		_aGrinenko, N I
700	1		_aGrinenko, A Y
700	1		_aFletcher, J
700	1		_aPetrakis, I L
700	1		_aKrystal, J H
773	0		_tNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _gvol. 25 _gno. 6 _gp. 936-47
856	4	0	_uhttps://doi.org/10.1016/S0893-133X(01)00346-3 _zAvailable from publisher's website
999			_c11662844 _d11662844